We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA to Replace Approvable, Not-Approvable Letters With Complete Responses
FDA to Replace Approvable, Not-Approvable Letters With Complete Responses
July 11, 2008
The FDA is doing away with “approvable” and “not-approvable” letters to drug companies as of Aug. 11, replacing them with “complete response letters” when CDER cannot approve a drug.